Skip to main content

Myelo Therapeutics

Berlin, Germany

Myelo Therapeutics develops innovative treatments in areas of high unmet medical needs.

$17.4M raised
Aug 2022
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Myelo Therapeutics

How much funding has Myelo Therapeutics raised?
Myelo Therapeutics has raised $17.4M in total funding. The most recent round was Grant. The last funding was announced in August 2022.
Who are Myelo Therapeutics's investors?
Myelo Therapeutics's investors include IBB Ventures, European Commission.
Where is Myelo Therapeutics headquartered?
Myelo Therapeutics is headquartered in Berlin, Germany.
What does Myelo Therapeutics do?
Myelo Therapeutics develops innovative treatments in areas of high unmet medical needs.
What stage is Myelo Therapeutics at?
Myelo Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Myelo Therapeutics — Funding & Investors." VCBacked, August 4, 2022, https://www.vcbacked.co/company/myelo-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2022). Myelo Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/myelo-therapeutics
Wikipedia (cite web)
{{cite web |title=Myelo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/myelo-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .